What is Opus Genetics's non cash share issuances?

Opus Genetics (IRD) reported non cash share issuances of $14.25K in Q4 2025.

What does non cash share issuances mean?

The value of equity instruments issued for non-cash consideration, such as services, intellectual property, or debt settlements. This metric highlights equity dilution that does not result in a direct cash inflow to the company.

Opus Genetics IRD Non Cash Share Issuances

Non Cash Share Issuances at other companies

KEE

Keel Infrastructure Corp. Common StockKEEL

$19.54M—

CleanSparkCLSK

$0—

KEE

Keel Infrastructure Corp. Common StockKEEL

$19.54M—

UBS

United BanksharesUBSI

0-100%

Frequency ElectronicsFEIM

15.4K—

MidCap Financial Investment CorporationMFIC

$110.04M—

Other financials

Income statement

See full

Revenue$2.2M-50.6%

Operating income-$14.4M-44.7%

Net income-$65.5M-700%

EPS (diluted)-$0.75-213%

Balance sheet

See full

Cash & equivalents$60.0M+43.5%

Total debt$1.2M—

Total equity-$45.8M-1,004%

Total assets$66.8M+38.7%

Cash flow

See full

Operating cash flow-$12.7M-41.5%

Valuation

See full

Market cap$307.14M+442%

Enterprise value$248.38M—

P/S25.6×+21.5×

Profitability

See full

Operating margin-359.1%-68.9pp

Net margin-892.4%-12,322pp

Returns & leverage

See full

Return on equity-449.4%-2,573pp

Debt / equity0.1×—

Current ratio7.1×+5.2×

Where this comes from

Reported directly by Opus Genetics in its filing.

Tagged under the XBRL concept ird:NonCashShareIssuances.

The official record: Opus Genetics’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opus Genetics's non cash share issuances.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Opus Genetics's non cash share issuances?: Opus Genetics (IRD) reported non cash share issuances of $14.25K in Q4 2025.
What does non cash share issuances mean?: The value of equity instruments issued for non-cash consideration, such as services, intellectual property, or debt settlements. This metric highlights equity dilution that does not result in a direct cash inflow to the company.